Short answer
Airsculpt Technologies, Inc. (AIRS) filed its Q3 2025 10-Q quarterly report on Nov 7, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $35M (down 17.8% year over year) with net income of −$10M.
Q3 2025 key financials · XBRL
- Revenue
- $35M
- −17.8% YoY · −20.5% QoQ
- Net income
- −$10M
- −57.5% YoY · −1509.5% QoQ
- Operating margin
- -27.9%
- EPS (diluted)
- −$0.16
- −45.5% YoY · −1500.0% QoQ
Source: XBRL data from the Airsculpt Technologies, Inc. (AIRS) Q3 2025 10-Q on SEC EDGAR. USD.
Airsculpt Technologies, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New operational risk: Closure of UK facility due to financial performance, triggering $2.3M impairment and $1M accelerated rent expense in Q3 2025
- Updated financial risk: Recorded $4.6M impairment on Salesforce software project, reflecting partial project discontinuation in Q3 2025
- Regulatory/legal risk: $0.9M prior litigation settlement costs impacting 2024 periods, no new litigation settlement costs in 2025 reported
- Market risk: Revenue down 16-18% YoY due to broader aesthetics industry weakness, leading to reduced procedures from 10,972 to 9,248 cases YTD
- Liquidity risk: Reliance on operational cash flow and $5M revolver; initiated $3M annual overhead cost reduction and paused new center expansions to conserve cash
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Airsculpt Technologies, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.